All Type of News
Consignment bioequivalence testing will likely be scrapped in May
The planned scrapping of consignment bioequivalence testing to ensure its transparency and facilitate the development of generic drugs will be available in May through a variety of procedures under the newly revised r...
M&A in pharmaceutical industries on rising rumor.
An M&A in the local pharmaceutical industries showed ever rising rumors these days in order to overcome impending environmental challenges stemming from the KORUS FTA, positive list system and massive transfers of dru...
Doctors should respond to suspicious prescription, lawmaker saysA medical bill that doctors or dental doctors should explain any suspicious contents of a prescription raised by a pharmacist will be proposed sooner or later, a lawmaker said o...
|
70 medical centers to undergo clinical test inspection
The government plans to conduct a nationwide, full-scale inspection of 70 clinical centers and their ongoing clinical trials within this year to ensure the safety of subjects, including ethnicity, the Korea Food and D...
New GMP validation to be released
The Korea Food and Drug Administration (KFDA) is considering implementing its new GMP validation system from this March, which is characterized by modifying the pharmaceutical control system from the current dosage fo...
KFDA to revise functional cosmetic review rules.
The KFDA announced on Feb. 5 in advance that the functional cosmetic review regulation should be revised.
At the end of January the KFDA already indicated the amendment for the review period of functional cosmetic ...
New pharmaceutical industrial part at Jecheon, Choongbuk province.
Following a successful completion of the 1st bio valley project establishment at Jecheon, Choongbuk province, the 2nd bio valley project has been also recently established. At the 1st bio valley industrial park, 65 co...
Dong-A Pharm China as launching pad for pharmaceutical export boostDong-A Pharm is gearing up to make inroads into China to capitalize on the China's growing demand for drugs and consolidate its leadership position in that country.
Dong-A sa...
|
Hanmi ranks 2nd in pharmaceutical sales
Hanmi Pharm ranked second with sales of 422.2 billion won last year, overtaking Yuhan's sales of 411.7 billion won.
Hanmi said on February 5 it posted 422.2 billion won in sales last year, up from 12.1 percent in 2...
Over one million patients receiving 3 MW of NHI benefits.
The National Health Insurance Corporation (NHIC) published "Analysis for 2005 NHI Patients with High Reimbursement" covering that number of the patients received more than 3 million won of NHI reimbursement in 2005 wa...
